Trastuzumab Botidotin Versus Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: A Phase III, Open-Label, Randomized Controlled Trial
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性，不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1200/jco-26-00602
文献链接: https://ascopubs.org/doi/10.1200/JCO-26-00602
其他信息:
出版社: American Society of Clinical Oncology (ASCO)
作者: Jian Zhang; Quchang Ouyang; Qingyuan Zhang; Huihui Li; Xu Wang; Ying Wang; Yongmei Yin; Shusen Wang; Yuanting Gu; Tao Sun; Jingfen Wang; Xinhong Wu; Fanfan Li; Xi Chen; Man Li; Jin Yang; Hua Yang; Zhengkui Sun; Jianyun Nie; Xiaojia Wang; Jian Liu; Xianjun Tang; Hao Wang; Zhan Huang; Weimin Xie; Wenyan Chen; Fan Li; Yuee Teng; Shuqun Zhang; Ru Zeng; Wenhui Wang; Lixia Ma; Yongli Gao; Haijun Yu; Xiguang Cao; Yan Qing; Xiaoping Jin; Junyou Ge; Hongxia Wang; Xichun Hu
